NeuroOne Medical Technologies Corporation NMTC
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -39.51% | -0.61% | 5.00% | 70.73% | 55.90% |
| Total Depreciation and Amortization | -9.41% | -0.58% | 3.48% | 6.00% | 6.61% |
| Total Amortization of Deferred Charges | -200.00% | -200.00% | -200.00% | -- | -- |
| Total Other Non-Cash Items | 47.64% | 15.31% | -32.05% | -53.55% | -32.36% |
| Change in Net Operating Assets | -1,746.72% | -23,757.14% | 80.69% | 55.04% | 92.86% |
| Cash from Operations | -77.25% | -52.47% | 11.92% | 74.23% | 64.63% |
| Capital Expenditure | -1.48% | -68.22% | 8.74% | 32.03% | 23.35% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -1.48% | -68.22% | 8.74% | 32.03% | 19.04% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -88.48% | 242.34% | 112.13% | 63.76% | -5.61% |
| Repurchase of Common Stock | 46.55% | 59.58% | -47.91% | -53.19% | -64.21% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -80.76% | -185.41% | -196.57% | -198.64% | 117.43% |
| Cash from Financing | -88.87% | 135.68% | 56.36% | 10.45% | 5.93% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -193.34% | 233.14% | 256.94% | 232.31% | 538.65% |